194 related articles for article (PubMed ID: 31823769)
21. Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4.
Wu C; He S; Liu J; Wang B; Lin J; Duan Y; Gao X; Li D
Scand J Immunol; 2018 May; 87(5):e12661. PubMed ID: 29570822
[TBL] [Abstract][Full Text] [Related]
22. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
[TBL] [Abstract][Full Text] [Related]
23. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
25. Treatment with a Toll-like Receptor 7 ligand evokes protective immunity against atherosclerosis in hypercholesterolaemic mice.
Karadimou G; Gisterå A; Gallina AL; Caravaca AS; Centa M; Salagianni M; Andreakos E; Hansson GK; Malin S; Olofsson PS; Paulsson-Berne G
J Intern Med; 2020 Sep; 288(3):321-334. PubMed ID: 32410352
[TBL] [Abstract][Full Text] [Related]
26. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Tipping P; Bobik A; Toh BH; Kyaw T
Cardiovasc Res; 2015 Jun; 106(3):443-52. PubMed ID: 25681396
[TBL] [Abstract][Full Text] [Related]
27. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
Butcher MJ; Waseem TC; Galkina EV
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
[TBL] [Abstract][Full Text] [Related]
28. Dyslipidemia-associated alterations in B cell subpopulation frequency and phenotype during experimental atherosclerosis.
Rincón-Arévalo H; Castaño D; Villa-Pulgarín J; Rojas M; Vásquez G; Correa LA; Ramírez-Pineda JR; Yassin LM
Atherosclerosis; 2016 Apr; 247():118-26. PubMed ID: 26897258
[TBL] [Abstract][Full Text] [Related]
29. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
[TBL] [Abstract][Full Text] [Related]
30. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
31. Ablation of Interferon Regulatory Factor 3 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice.
Liu H; Cheng WL; Jiang X; Wang PX; Fang C; Zhu XY; Huang Z; She ZG; Li H
Hypertension; 2017 Mar; 69(3):510-520. PubMed ID: 28115514
[TBL] [Abstract][Full Text] [Related]
32. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
[TBL] [Abstract][Full Text] [Related]
33. T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice.
Li BW; de Bruijn MJ; Tindemans I; Lukkes M; KleinJan A; Hoogsteden HC; Hendriks RW
Eur J Immunol; 2016 Jun; 46(6):1392-403. PubMed ID: 27062360
[TBL] [Abstract][Full Text] [Related]
34. IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function.
Noval Rivas M; Burton OT; Oettgen HC; Chatila T
J Allergy Clin Immunol; 2016 Sep; 138(3):801-811.e9. PubMed ID: 27177780
[TBL] [Abstract][Full Text] [Related]
35. Sex differences exist in adult heart group 2 innate lymphoid cells.
Peng H; Wu S; Wang S; Yang Q; Wang L; Zhang S; Huang M; Li Y; Xiong P; Zhang Z; Cai Y; Li L; Deng Y; Deng Y
BMC Immunol; 2022 Oct; 23(1):52. PubMed ID: 36316644
[TBL] [Abstract][Full Text] [Related]
36. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation.
Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T
Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554
[TBL] [Abstract][Full Text] [Related]
37. A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA
Front Immunol; 2024; 15():1317522. PubMed ID: 38524132
[TBL] [Abstract][Full Text] [Related]
38. Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury.
Cao Q; Wang R; Niu Z; Chen T; Azmi F; Read SA; Chen J; Lee VWS; Zhou C; Julovi S; Huang Q; Wang YM; Starkey MR; Zheng G; Alexander SI; George J; Wang Y; Harris DCH
JHEP Rep; 2023 Oct; 5(10):100837. PubMed ID: 37691688
[TBL] [Abstract][Full Text] [Related]
39. Group 2 Innate Lymphoid Cells (ILC2s) Are Key Mediators of the Inflammatory Response in Polymicrobial Sepsis.
Chun TT; Chung CS; Fallon EA; Hutchins NA; Clarke E; Rossi AL; Cioffi WG; Heffernan DS; Ayala A
Am J Pathol; 2018 Sep; 188(9):2097-2108. PubMed ID: 29935165
[TBL] [Abstract][Full Text] [Related]
40. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
